Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radhika Narain

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Genes & Development|December 5, 2024
Forcing the code: tension modulates signaling to drive morphogenesis and malignancyRadhika Narain, Jonathon M Muncie-Vasic, Valerie M Weaver
Npj Imaging|July 2, 2025
Increased imaging ligand hydrophilicity and improved pharmacokinetic properties provides enhanced in vivo targeting of fibroblast activation proteinRadhika Narain, Ian Nessler, Paul L Richardson, et al.
Science Translational Medicine|February 1, 2019
A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapyMatthew T Wolf, Sudipto Ganguly, Tony L Wang, et al.
Nature Communications|May 5, 2026
NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancerPavla Ticha, Jason J Northey, Radhika Narain, et al.
Science Translational Medicine|April 17, 2020
Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humansLiam Chung, David R Maestas, Andriana Lebid, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Genes & Development|December 5, 2024
Forcing the code: tension modulates signaling to drive morphogenesis and malignancyRadhika Narain, Jonathon M Muncie-Vasic, Valerie M Weaver
Npj Imaging|July 2, 2025
Increased imaging ligand hydrophilicity and improved pharmacokinetic properties provides enhanced in vivo targeting of fibroblast activation proteinRadhika Narain, Ian Nessler, Paul L Richardson, et al.
Science Translational Medicine|February 1, 2019
A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapyMatthew T Wolf, Sudipto Ganguly, Tony L Wang, et al.
Nature Communications|May 5, 2026
NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancerPavla Ticha, Jason J Northey, Radhika Narain, et al.
Science Translational Medicine|April 17, 2020
Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humansLiam Chung, David R Maestas, Andriana Lebid, et al.
Pageof 1